Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

> more severe unknown incidents like thyroid and pancreatic cancer

Alcoholism, diabetes and obesity don't give you long enough to get these cancers. Even if we had evidence GLP-1 agonists massively increased the risk of these cancers, which we don't, despite them having been studied and prescribed for decades [1][2], the tradeoff makes sense for much of the population.

[1] https://en.wikipedia.org/wiki/GLP-1_receptor_agonist#Approve...

[2] https://en.wikipedia.org/wiki/Exenatide



People also talk about the cost, but that cost will come down, and besides the cost to society from alcoholism and obesity are absolutely staggering.


> the cost to society from alcoholism and obesity

To put that into perspective, annual cost of diabetes to America is $1,200 per capita ($1,300 adjusted for inflation [2]. 40% more than a month of Ozempic [3].

One twelfth of Americans have diabetes [4]. If the government could negotiate just a 10% bulk discount, the payback period on buying every American with diabetes Ozempic would be around a year. Even if everyone ceased treatment after that, even if you only did this for a couple years, we'd see a permanent boost in productivity and health across the American population.

[1] https://pubmed.ncbi.nlm.nih.gov/37909353/

[2] https://www.usinflationcalculator.com

[3] https://ro.co/weight-loss/ozempic-cost-without-insurance/

[4] https://www.niddk.nih.gov/health-information/health-statisti...


Government could build their own plants, these drugs are not under patent, just the drug+delivery mechanism is. This says $5 per month as actual costs.

https://www.healthline.com/health-news/how-affordable-could-...


> these drugs are not under patent

"Semaglutide is expected to become patent-free in the United States no earlier than December 2031" [1].

We could probably strike a volume deal for ~$200 for 5 years and then $75 (the upper end of your study’s estimate for manufacturing cost) for another 5.

[1] https://www.drugpatentwatch.com/p/tradename/OZEMPIC


https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held-...

My understanding is that they are patentening the drug+device and or the dosing, not the molecule. Looks like the FTC is clamping down on it.


This really depends how you calculate cost to society. Everyone dies, and the healthiest people die the slowest. So when you look at the cost of the alternatives the difference looks much smaller or non-existant. If the alternative of getting a heart attack at 57 is retiring at 67, collecting social security for 20 years, getting Alzheimers at 73 and spending 10 years in a Medicare funded memory care facility, obesity and alcoholism don't look as expensive.


> really depends how you calculate cost to society

Age doesn't cost society, morbidity does [1]. A society of long-lived healthy people is richer than one of the short-lived obese.

[1] https://pubmed.ncbi.nlm.nih.gov/37117804/




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: